These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 19317162)

  • 1. [Clinical observation on ziyin tongbi decoction in treating benign prostatic hyperplasia].
    Guo J; Song CS; Han Q
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Dec; 28(12):1082-5. PubMed ID: 19317162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical observation on auxiliary treatment of hormone dependence dermatitis by shufeng liangxue decoction].
    Bai YS; Zhou CY; Wang JQ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Dec; 28(12):1121-3. PubMed ID: 19317172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fushile: a safe and effective therapeutic for benign prostatic hyperplasia].
    Shang XJ; Liu ZY; Liu ZF; Sun YH; Huang YF
    Zhonghua Nan Ke Xue; 2008 Mar; 14(3):227-30. PubMed ID: 18488335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Observation of the therapeutic effect of qianlie sanyu capsule on benign prostatic hyperplasia].
    Xi JY; He JQ; Zhang X; Liu LF; Lu FG
    Zhonghua Nan Ke Xue; 2005 Jan; 11(1):68-9, 75. PubMed ID: 15704687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical study on Kangquan Recipe (康泉方) for benign prostatic hyperplasia patients: a randomized controlled trial.
    Huang YP; Wen YH; Wu GH; Hong ZF; Xu SW; Peng AX
    Chin J Integr Med; 2014 Dec; 20(12):949-54. PubMed ID: 25428342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT study.
    Roehrborn CG; Barkin J; Tubaro A; Emberton M; Wilson TH; Brotherton BJ; Castro R
    BJU Int; 2014 Apr; 113(4):623-35. PubMed ID: 24127818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Longbishu Capsule combined with mesylate doxazosin: an efficacious therapy for benign prostatic hyperplasia].
    Chang DG; Li GS; Peng CH; Yu XJ; Zhang PH; Bi MS; Chen DA; You YD; Yang XZ
    Zhonghua Nan Ke Xue; 2015 Feb; 21(2):165-9. PubMed ID: 25796693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of tadalafil once daily in the treatment of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: results of an international randomized, double-blind, placebo-controlled trial.
    Porst H; Kim ED; Casabé AR; Mirone V; Secrest RJ; Xu L; Sundin DP; Viktrup L;
    Eur Urol; 2011 Nov; 60(5):1105-13. PubMed ID: 21871706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of electroacupuncture in treating 93 patients with benign prostatic hyperplasia].
    Yang T; Zhang XQ; Feng YW
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Nov; 28(11):998-1000. PubMed ID: 19213342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of Benign Prostatic Hyperplasia by Longbishu Capsule Combined Doxazosin Mesylate Tablet].
    Song CS; Zhao JY; Guo J; Chang DG; Chen L; Zhang R; Wang F
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Dec; 36(12):1465-1469. PubMed ID: 30650291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A comparative study on different doses of cernilton for preventing the clinical progression of benign prostatic hyperplasia].
    Xu J; Qian WQ; Song JD
    Zhonghua Nan Ke Xue; 2008 Jun; 14(6):533-7. PubMed ID: 18649754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of tadalafil once daily on maximum urinary flow rate in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    Roehrborn CG; Chapple C; Oelke M; Cox D; Esler A; Viktrup L
    J Urol; 2014 Apr; 191(4):1045-50. PubMed ID: 24445278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adding Cyclooxygenase-2 inhibitor to alpha blocker for patients with benign prostate hyperplasia and elevated serum prostate specific antigen could not improve prostate biopsy detection rate but improve lower urinary tract symptoms.
    Jhang JF; Jiang YH; Kuo HC
    Int J Clin Pract; 2013 Dec; 67(12):1327-33. PubMed ID: 24246211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical evaluation on fengweicao granule in treating benign prostatic hyperplasia].
    Xue BX; Shan YX; Xiang G
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 May; 28(5):456-8. PubMed ID: 18677810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bipolar plasma enucleation of the prostate vs open prostatectomy in large benign prostatic hyperplasia cases - a medium term, prospective, randomized comparison.
    Geavlete B; Stanescu F; Iacoboaie C; Geavlete P
    BJU Int; 2013 May; 111(5):793-803. PubMed ID: 23469933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Doxazosin in the gastrointestinal therapeutic system (GITS) and doxazosin standard in patients with benign prostatic hyperplasia. Double-blind trial of efficacy and tolerability].
    Gratzke P; Kirby RS
    Fortschr Med Orig; 2000 Jul; 118 Suppl 2():83-92. PubMed ID: 15700491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of 8-mg once-daily vs 4-mg twice-daily silodosin in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (SILVER Study): a 12-week, double-blind, randomized, parallel, multicenter study.
    Choo MS; Song M; Kim JH; Lee KS; Kim JC; Kim SW; Yang SK; Lee JG; Lee JZ; Kim DK; Park WH; Kim KD; Na YG; Kwon DD; Paick JS
    Urology; 2014 Apr; 83(4):875-81. PubMed ID: 24529580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pooled analysis of individual patient data from registrational trials of silodosin in the treatment of non-neurogenic male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH).
    Novara G; Chapple CR; Montorsi F
    BJU Int; 2014 Sep; 114(3):427-33. PubMed ID: 24571313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardura monotherapy versus combination therapy of cardura and tolterodine L-tartrate tablets for II° ? benign prostatic hyperplasia with overactive bladder].
    Wang YY; Shi GW; He JY; Zhang YB
    Zhonghua Nan Ke Xue; 2013 Dec; 19(12):1099-102. PubMed ID: 24432622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tadalafil once daily for lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a randomized placebo- and tamsulosin-controlled 12-week study in Asian men.
    Yokoyama O; Yoshida M; Kim SC; Wang CJ; Imaoka T; Morisaki Y; Viktrup L
    Int J Urol; 2013 Feb; 20(2):193-201. PubMed ID: 22958078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.